Literature DB >> 25346

The pH of the prostatic fluid in health and disease: implications of treatment in chronic bacterial prostatitis.

A Pfau, S Perlberg, A Shapira.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 25346     DOI: 10.1016/s0022-5347(17)57497-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  14 in total

1.  Fluoroquinolone Antimicrobial Agents in the Treatment of Prostatitis and Recurrent Urinary Tract Infections in Men.

Authors:  F M E Wagenlehner; K G Naber
Journal:  Curr Infect Dis Rep       Date:  2005-01       Impact factor: 3.725

Review 2.  The role of quinolones in the treatment of chronic bacterial prostatitis.

Authors:  K G Naber
Journal:  Infection       Date:  1991       Impact factor: 3.553

3.  A new method for assaying antimicrobials in the prostate.

Authors:  A C Philpott; E D Crawford; G J Miller
Journal:  Infection       Date:  1991       Impact factor: 3.553

4.  The treatment of chronic bacterial prostatitis.

Authors:  A Pfau
Journal:  Infection       Date:  1991       Impact factor: 3.553

5.  [Enoxacin concentration in seminal fluid, in prostate secretions and in prostatic adenoma tissue following oral administration or intravenous infusion].

Authors:  K G Naber; F Sörgel; F Kees; H Schumacher; G Sigl; J Zürcher; S Berger
Journal:  Infection       Date:  1989       Impact factor: 3.553

Review 6.  Diagnostic and therapeutic problems in prostatitis. Therapeutic position of ofloxacin.

Authors:  J Aagaard; P O Madsen
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

7.  A host defense mechanism involving CFTR-mediated bicarbonate secretion in bacterial prostatitis.

Authors:  Chen Xie; Xiaoxiao Tang; Wenming Xu; Ruiying Diao; Zhiming Cai; Hsiao Chang Chan
Journal:  PLoS One       Date:  2010-12-07       Impact factor: 3.240

8.  A re-appraisal of antibiotic susceptibility tests in the management of bacterial prostatitis.

Authors:  G Kazanci; S Yildiz; R Büjükalpelli
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

Review 9.  Pefloxacin clinical pharmacokinetics.

Authors:  F Bressolle; F Gonçalves; A Gouby; M Galtier
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

Review 10.  Pharmacokinetic disposition of quinolones in human body fluids and tissues.

Authors:  F Sörgel; U Jaehde; K Naber; U Stephan
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.